VFA
TRIV

Virtus Fund Advisers’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Virtus Fund Advisers’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-633
Closed -$10K – 2568
2014
Q2 		$10K Buy
+633
New +$9.61K ﹤0.01% 2769

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtus Fund Advisers's TRIV Position: Q3 2014 in Review

Virtus Fund Advisers sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2014, closing a stake of 633 shares — an estimated $10K sold.

Virtus Fund Advisers first reported a position in TRIV in Q2 2014 and held it in 1 quarter. The position peaked at $10K in Q2 2014. 41 funds tracked by Wall St. Rank hold TRIV as of Q3 2014.

  • Virtus Fund Advisers reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 633 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2014, an estimated $10K.
  • Virtus Fund Advisers first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $10K in Q2 2014.
  • 41 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.